HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A J Scheen Selected Research

sibutramine (Meridia)

10/2010[Suspension of the commercialization of sibutramine and rosiglitazone in Europe].
1/2010Cardiovascular risk-benefit profile of sibutramine.
5/2005[Obesity and type 2 diabetes].
12/2002New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
4/2002Results of obesity treatment.
9/2001[Pharma-clinics. Medication of the month. Sibutramine (Reductil)].
1/2001[Clinical study of the month. After the storm over central anorectic agents, the "STORM" study of sibutramine].
3/2000Antiobesity pharmacotherapy in the management of type 2 diabetes.
3/2000Treatment of diabetes in patients with severe obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A J Scheen Research Topics

Disease

140Type 2 Diabetes Mellitus (MODY)
03/2022 - 03/2000
48Insulin Resistance
09/2017 - 01/2000
34Weight Loss (Weight Reduction)
09/2019 - 03/2000
28Cardiovascular Diseases (Cardiovascular Disease)
12/2018 - 01/2000
27Heart Failure
03/2022 - 01/2003
27Hypertension (High Blood Pressure)
01/2020 - 01/2000
21Obesity
01/2019 - 01/2000
20Body Weight (Weight, Body)
09/2020 - 03/2000
18Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2019 - 03/2000
17Weight Gain
05/2020 - 04/2002
17Myocardial Infarction
11/2018 - 12/2000
17Diabetes Mellitus
10/2015 - 02/2000
16Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014 - 04/2000
15Coronary Disease (Coronary Heart Disease)
09/2017 - 09/2000
14Stroke (Strokes)
09/2017 - 10/2000
13Renal Insufficiency (Renal Failure)
03/2022 - 08/2006
13Overweight
01/2019 - 09/2001
12Glucose Intolerance
04/2010 - 03/2000
9Morbid Obesity
09/2012 - 03/2000
8Lactic Acidosis
03/2021 - 05/2002
8Acute Coronary Syndrome
09/2015 - 03/2004
7Inflammation (Inflammations)
05/2022 - 10/2009
7Chronic Renal Insufficiency
03/2021 - 03/2008
7Coronary Artery Disease (Coronary Atherosclerosis)
08/2013 - 07/2002
6Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 05/2005
6Diabetes Complications
12/2018 - 05/2000
5COVID-19
03/2021 - 01/2020
5Neoplasms (Cancer)
12/2018 - 12/2002
5Atherosclerosis
06/2015 - 04/2003
4Atrial Fibrillation
02/2021 - 10/2009
4Hemorrhage
02/2021 - 09/2006
4Infections
01/2020 - 03/2004
4Albuminuria
01/2019 - 12/2005
4Breast Neoplasms (Breast Cancer)
12/2018 - 09/2009
4Nausea
04/2014 - 01/2008
4Thrombosis (Thrombus)
04/2011 - 03/2001

Drug/Important Bio-Agent (IBA)

71Glucose (Dextrose)FDA LinkGeneric
04/2021 - 01/2000
69Insulin (Novolin)FDA Link
02/2019 - 01/2000
51Metformin (Glucophage)FDA LinkGeneric
03/2021 - 03/2000
21Hypoglycemic Agents (Hypoglycemics)IBA
05/2020 - 05/2001
18Sodium-Glucose Transporter 2 InhibitorsIBA
03/2022 - 08/2011
17Pharmaceutical PreparationsIBA
03/2020 - 01/2001
17Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2015 - 12/2002
17LipidsIBA
09/2015 - 05/2000
14ThiazolidinedionesIBA
11/2008 - 03/2000
12Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2021 - 02/2000
11Sodium-Glucose Transport ProteinsIBA
01/2022 - 11/2015
11Dipeptidyl-Peptidase IV InhibitorsIBA
05/2020 - 08/2010
10Glucagon-Like Peptide 1 (GLP 1)IBA
09/2019 - 06/2004
10HDL CholesterolIBA
03/2019 - 02/2005
9Antihypertensive Agents (Antihypertensives)IBA
02/2021 - 01/2003
9Sitagliptin Phosphate (Januvia)FDA Link
09/2020 - 02/2008
9Pioglitazone (Actos)FDA Link
12/2018 - 01/2001
9LDL CholesterolIBA
09/2015 - 03/2004
9sibutramine (Meridia)FDA Link
10/2010 - 03/2000
8empagliflozinIBA
04/2021 - 09/2015
8DiureticsIBA
04/2018 - 01/2000
8Rosiglitazone (Avandia)FDA Link
10/2010 - 01/2001
7Atorvastatin (Lipitor)FDA Link
02/2021 - 12/2000
7CytokinesIBA
01/2020 - 04/2000
7Triglycerides (Triacylglycerol)IBA
03/2019 - 01/2006
7IncretinsIBA
12/2014 - 08/2007
7Blood Glucose (Blood Sugar)IBA
02/2014 - 05/2000
7Orlistat (Xenical)FDA Link
05/2005 - 03/2000
6CholesterolIBA
02/2021 - 12/2000
6PerindoprilFDA LinkGeneric
02/2021 - 11/2001
6BiguanidesIBA
11/2020 - 06/2001
6CreatinineIBA
01/2019 - 05/2009
6Amlodipine (Norvasc)FDA LinkGeneric
10/2014 - 01/2003
6RimonabantIBA
05/2008 - 05/2005
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2022 - 03/2001
5Insulin Glargine (Lantus)FDA Link
04/2019 - 02/2004
5LiraglutideFDA Link
12/2018 - 11/2008
5Glucagon-Like Peptide-1 Receptor AgonistsIBA
12/2018 - 08/2007
5Exenatide (Byetta)FDA Link
04/2014 - 06/2004
5Angiotensin Receptor AntagonistsIBA
04/2008 - 02/2001
5AdiponectinIBA
01/2008 - 09/2003
4ReninIBA
01/2020 - 05/2003
4Fenofibrate (CiL)FDA LinkGeneric
03/2019 - 12/2005
4Glucagon-Like Peptide-1 ReceptorIBA
02/2019 - 01/2018
4Biomarkers (Surrogate Marker)IBA
01/2019 - 04/2000
4glimepiride (Amarel)FDA LinkGeneric
11/2018 - 03/2000
4Short-Acting InsulinIBA
10/2015 - 04/2002
4oxidized low density lipoproteinIBA
09/2015 - 03/2004
4Glucagon (Glukagon)FDA Link
08/2015 - 11/2010
4Biological ProductsIBA
07/2014 - 04/2000
4AcarboseFDA LinkGeneric
01/2013 - 10/2001
4Hormones (Hormone)IBA
08/2012 - 12/2005
42,4-thiazolidinedione (thiazolidinedione)IBA
04/2012 - 12/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2011 - 03/2000
4Fibric Acids (Fibrates)IBA
09/2010 - 05/2003
4Anti-Obesity Agents (Antiobesity Drugs)IBA
01/2010 - 03/2000
4Ramipril (Altace)FDA LinkGeneric
04/2008 - 02/2000

Therapy/Procedure

61Therapeutics
05/2022 - 01/2000
15Glycemic Control
02/2012 - 03/2000
10Secondary Prevention
10/2019 - 02/2000
9Bariatric Surgery
09/2012 - 03/2000
5Injections
01/2020 - 02/2004
5Contraindications
08/2013 - 01/2010
4Stents
11/2008 - 03/2001